Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05035810 · ClinicalTrials.gov registry record · Phase 3

A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee Marching On for Veterans With Osteoarthritis of the Knee

A Phase 3 study of Osteoarthritis of the Knee, sponsored by VA Office of Research and Development.

Active
Registry status
Phase 3
Development phase
221
Enrollment target
4
Study locations

NCT05035810 is a Phase 3 study of Osteoarthritis of the Knee that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 221 participants, roughly in line with the 207-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target. The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05035810, a Phase 3 study of Osteoarthritis of the Knee, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
221 participants
Enrollment target
4
Study locations

Study Summary

Knee osteoarthritis (KOA) is one of the most common and disabling conditions among Veterans. Management of KOA is challenging as there are few effective treatments other than joint replacement. Importantly, low levels of physical activity in patients with knee problems might worsen pain and disability. This study aims to determine the feasibility of using methods to change behavior that use social incentives and promote physical activity through playing games and interacting with a web-based platform. The study will also evaluate an important and widely used treatment, namely corticosteroid injections. Participants will be randomized into one of 4 arms and will receive a different combination of social incentives and injections. The study will evaluate which approach is most effective at promoting physical activity and reducing pain and disability.

Conditions Studied

Interventions

  • BEHAVIORAL Social Incentives and Gamification to Promote Exercise
  • DRUG Corticosteroid Injection given in A-B order
  • BEHAVIORAL No Social Incentive applied
  • DRUG Procedure: Corticosteroid Injection given in B-A order

Study Locations (4)

District of Columbia

  • Washington DC VA Medical Center, Washington, DC - Washington D.C.

Nebraska

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE - Omaha

Pennsylvania

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA - Philadelphia

Washington

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle

Trial Details

FieldValue
Enrollment Target 221 participants
Start Date 2022-03-14
Est. Completion 2025-12-31
Phase Phase 3

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05035810

The ClinicalTrials.gov registry entry for NCT05035810 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 207-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis of the Knee appearing as the primary indexed condition, and to 4 interventions - of which Social Incentives and Gamification to Promote Exercise is the first listed.

NCT05035810 reports 4 study locations spanning 4 distinct geographic areas - top geographies include District of Columbia, Nebraska, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05035810 about?

NCT05035810 is a clinical study titled "A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee Marching On for Veterans With Osteoarthritis of the Knee". Knee osteoarthritis (KOA) is one of the most common and disabling conditions among Veterans. Management of KOA is challenging as there are few effective treatments other than joint replacement. Importantly, low levels of physical activity in patients with knee problems might worsen pain and disabili...

What is the current status of trial NCT05035810?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 221 participants. The study started on 2022-03-14. Estimated completion is 2025-12-31.

What conditions does trial NCT05035810 study?

This clinical trial studies the following conditions: Osteoarthritis of the Knee.

What interventions are being tested in trial NCT05035810?

The interventions under investigation include: Social Incentives and Gamification to Promote Exercise (BEHAVIORAL), Corticosteroid Injection given in A-B order (DRUG), No Social Incentive applied (BEHAVIORAL), Procedure: Corticosteroid Injection given in B-A order (DRUG).

Who is sponsoring clinical trial NCT05035810?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05035810 being conducted?

This trial has 4 study locations across District of Columbia, Nebraska, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis of the Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.